Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA)

Vaccine

Volumn 30, Issue SUPPL. 6, 2012, Pages

  Shibl, Atef M ^a,c   Memish, Ziad A ^b,c   Al Kattan, Khaled M ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b MINISTRY OF HEALTH   (Saudi Arabia)

^c ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Pediatric; Saudi Arabia; Serotype; Streptococcus pneumoniae

Indexed keywords

ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD CULTURE; CEREBROSPINAL FLUID; CHILD; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SAUDI ARABIA; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, BACTERIAL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SAUDI ARABIA; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84870852056     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.030     Document Type: Review

References (21)

1. Shibl A.M. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004). Clin Microbiol Infect 2008, 14(9):876-879.
2. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec 2007;82(12):93-104.
3. Wardlaw T., Johansson E.W., Hodge M. Pneumonia: the forgotten killer of children 2006, UNICEF and World Health Organization.
4. Centers for Disease Control and Prevention Prevention of pneumococcal disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 1997, 46(RR-8):1-24. available at: http://www.cdc.gov/mmwr/PDF/RR/RR4608.pdf. (last accessed April 2012).
5. Arai S., Konda T., Wad A., Matsunaga Y., Okabe N., Watanabe H., et al. Use of antiserum-coated latex particles for serotyping Streptococcus pneumoniae. Microbiol Immunol 2001, 45:159-162.
6. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., Dagan R. Site-specific disease of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitismedia and acute conjunctivitis. Pediatr Infect Dis J 2006, 25:602-607.
7. Felmingham D., Gruneberg R.N. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000, 45:191-203. The Alexander Project Group.
8. Apelbaum P.C. Antimicrobial resistance in Streptococcus pneumoniae. Clin Infect Dis 1992, 15:77-83.
9. Memish Z.A., Balkhy H.H., Shibl A.M., Barrozo C.P., Gray G.C. Streptococcus pneumoniae in Saudi Arabia: antibiotic resistance and serotypes of recent clinical isolates. Int J Antimicrob Agents 2004, 23:32-38.
10. Twum-Danso K., Al-Mazrou A.M., Kambal A.M., AI-Zamil F.A. Penicillin resistance in serogroups/serotypes of Streptococcus pneumoniae causing invasive infections in Central Saudi Arabia. Saudi Med J 2003, 24:1210-1213.
11. Memish Z., Alotaibi B., Al Shaalan M., Alola S., Althaqafi A. A retrospective epidemiological study of invasive pneumococcal disease in children aged 0-5 years in the Kingdom of Saudi Arabia. Poster presented at: the 6th International Symposium on Pneumococci & Pneumococcal Diseases 2008.
12. Memish Z.A., El-Saed A., Al-Otaibi B., Al Shaalan M., Al Alola S., Thaqafi A.O. Epidemiology of invasive pneumococcal infection in children aged five years and under in Saudi Arabia: a five-year retrospective surveillance study. Int J Infect Dis 2010, 14:e708-e712.
13. Al-Tawfiq J.A. Antibiotic resistance of pediatric isolates of Streptococcus pneumoniae in a Saudi Arabian hospital from 1999 to 2004. Med Sci Monit 2006, 12(11):CR471-CR475.
14. Chowdhury M.N.H., Khaliq M.R.A., Kambal A.M. Penicillin-resistant Streptococcus pneumoniae in Riyadh, Saudi Arabia. Int J Antimicrob Agents 1995, 6:37-41.
15. Policy statement: recommendations for the prevention of pneumococcal conjugate vaccine (Prevnar). Pediatrics 2000, 106:362-366. American Academy of Pediatrics Committee on Infectious Disease.
16. World Health Organization Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000-2008. MMWR 2008, 57:1148-1151.
17. Centers for Disease Control and Prevention (CDC) Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000, 49:1-35.
18. World Health Organization. Detailed review paper on pneumococcal conjugate vaccine: presented to the WHO Strategic Group of Experts on Immunization, November 2006. (last accessed May 2011). http://www.who.int/immunization/sage/SAGE_wg_detailedreview_pneumoVaccine.pdf.
19. Shibl A., Memish Z., Pelton S. Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt. Int J Antimicrob Agents 2009, 410(33):e1-e9.
20. Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use. Part I. Clin Infect Dis 2000, 30:100-121.
21. Frayha H.H., Al Mazrou Y.Y. Vaccination against invasive pneumococcal disease in Saudi Arabia: where do we stand?. Ann Saudi Med 2005, 25:90-93.